These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 21586307)

  • 1. Local transdermal delivery of phenylephrine to the anal sphincter muscle using microneedles.
    Baek C; Han M; Min J; Prausnitz MR; Park JH; Park JH
    J Control Release; 2011 Sep; 154(2):138-47. PubMed ID: 21586307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hollow microneedles for targeted delivery of phenylephrine to treat fecal incontinence.
    Jun H; Han MR; Kang NG; Park JH; Park JH
    J Control Release; 2015 Jun; 207():1-6. PubMed ID: 25828366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of a Sol-Gel Formulation of Phenylephrine Using Low-Temperature Hollow Microneedle for Treatment of Intermittent Fecal Incontinence.
    Lee H; Park JH; Park JH
    Pharm Res; 2017 Dec; 34(12):2809-2816. PubMed ID: 29181686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly (vinyl alcohol) microneedles: Fabrication, characterization, and application for transdermal drug delivery of doxorubicin.
    Nguyen HX; Bozorg BD; Kim Y; Wieber A; Birk G; Lubda D; Banga AK
    Eur J Pharm Biopharm; 2018 Aug; 129():88-103. PubMed ID: 29800617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication, characterization and application of sugar microneedles for transdermal drug delivery.
    Nguyen HX; Banga AK
    Ther Deliv; 2017 Mar; 8(5):249-264. PubMed ID: 28361607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal delivery of insulin using microneedles in vivo.
    Martanto W; Davis SP; Holiday NR; Wang J; Gill HS; Prausnitz MR
    Pharm Res; 2004 Jun; 21(6):947-52. PubMed ID: 15212158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
    Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
    J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and strategies in developing microneedle patches for transdermal delivery of protein and peptide therapeutics.
    Wu F; Yang S; Yuan W; Jin T
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1292-8. PubMed ID: 22201589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controllable coating of microneedles for transdermal drug delivery.
    Chen J; Qiu Y; Zhang S; Yang G; Gao Y
    Drug Dev Ind Pharm; 2015 Mar; 41(3):415-22. PubMed ID: 24378200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolving Microneedles Patch: A Promising Approach for Advancing Transdermal Delivery of Antischizophrenic Drug.
    Umar QU; Khan MI; Ahmad Z; Akhtar MF; Sohail MF; Madni A; Erum A; Ayesha B; Ain QU; Mushtaq A
    J Pharm Sci; 2024 Oct; 113(10):3078-3087. PubMed ID: 39154735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the applications of microneedles in dermatology.
    Sabri AH; Ogilvie J; Abdulhamid K; Shpadaruk V; McKenna J; Segal J; Scurr DJ; Marlow M
    Eur J Pharm Biopharm; 2019 Jul; 140():121-140. PubMed ID: 31059780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing.
    Rajabi M; Roxhed N; Shafagh RZ; Haraldson T; Fischer AC; Wijngaart WV; Stemme G; Niklaus F
    PLoS One; 2016; 11(12):e0166330. PubMed ID: 27935976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel dissolving microneedles for enhanced transdermal delivery of levonorgestrel: In vitro and in vivo characterization.
    Yao G; Quan G; Lin S; Peng T; Wang Q; Ran H; Chen H; Zhang Q; Wang L; Pan X; Wu C
    Int J Pharm; 2017 Dec; 534(1-2):378-386. PubMed ID: 29051119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple method of microneedle array fabrication for transdermal drug delivery.
    Kochhar JS; Goh WJ; Chan SY; Kang L
    Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo evaluation of a microneedle array device for transdermal application.
    Indermun S; Choonara YE; Kumar P; du Toit LC; Modi G; van Vuuren S; Luttge R; Pillay V
    Int J Pharm; 2015 Dec; 496(2):351-9. PubMed ID: 26453791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of patents for microneedle application devices allowing fluid injections through the skin.
    Lhernould MS; Tailler S; Deleers M; Delchambre A
    Recent Pat Drug Deliv Formul; 2015; 9(2):146-57. PubMed ID: 25770583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview on the advantages and limitations of 3D printing of microneedles.
    Ozyilmaz ED; Turan A; Comoglu T
    Pharm Dev Technol; 2021 Nov; 26(9):923-933. PubMed ID: 34369288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microneedles: A smart approach and increasing potential for transdermal drug delivery system.
    Waghule T; Singhvi G; Dubey SK; Pandey MM; Gupta G; Singh M; Dua K
    Biomed Pharmacother; 2019 Jan; 109():1249-1258. PubMed ID: 30551375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin.
    Kim M; Jung B; Park JH
    Biomaterials; 2012 Jan; 33(2):668-78. PubMed ID: 22000788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.